From Lead and Oil to Retinoids and SPF: How Skin Care Became a Science

Skin care has rarely been only one thing. For most of recorded history, a substance put on the body could alter appearance, protect the skin from climate, or address a complaint without fitting the modern division between cosmetic and medicine. Oils might soften, pigments might define, waxes might form a barrier, and plant materials might be valued for both their smell and their perceived therapeutic usefulness. The preparation was judged by what it did visibly or immediately, while its ingredients were understood through local knowledge, inherited practice, and the materials available to a household or practitioner.

That overlap helps explain the striking example of Queen Elizabeth I. In Elizabethan England, she used Venetian ceruse, a facial whitener made from lead and vinegar, to cover smallpox scars and produce the pale complexion associated with her appearance. The material could accomplish an immediate visual purpose, but historical accounts associate repeated use with skin discoloration, hair loss, and other health risks. Its appeal and its danger belonged to the same preparation: the ingredient produced a desired effect, yet the visible result did not disclose its longer-term biological cost.

Venetian ceruse therefore presents skin care's oldest problem in unusually clear form. How could something mixed for appearance or relief become a standardized product whose safety and claims could be judged? The question is not simply when people began caring about their skin. They had done so for centuries. The question is how the topical preparation changed status: from a locally made substance whose authority rested largely on custom and apparent results, to a portable product made through controlled processes, and finally to an item increasingly subject to public-health law. The history is a history of materials, but also of repeatability, packaging, evidence, and responsibility.

Before modern chemistry separated cosmetics from medicine, skin care was a working mixture. Ancient Egyptian evidence shows that people prepared, stored, and applied substances through recognizable recipes and tools. Around 3000 BCE, kohl made with galena, a lead-sulfide mineral, produced the strongly lined-eye effect associated with Egyptian cosmetics. The practice also had protective and medicinal associations, so its place in Egyptian life cannot be reduced to decoration.

The material record makes that practice concrete. Egyptian cosmetic evidence includes applicators, wooden bowls, and terracotta kohl pots. Surviving applicators date approximately to 1575–1194 BCE, showing that cosmetic substances were handled through objects suited to mixing, keeping, and applying them. A kohl pot was therefore part of a small technology of topical use: the substance had to be prepared in a workable form, preserved, and transferred to the body with some degree of control.

Kohl belonged to a broader ingredient system. Egyptian preparations combined mineral pigments with materials derived from plants and animals. Malachite and copper compounds supplied mineral color; plant oils, animal fats, and waxes could provide bases or structure. Reported herbs included thyme, marjoram, chamomile, lavender, and aloe. These ingredients did not fit neatly into modern categories such as color cosmetics, moisturizers, and treatments. Their purposes overlapped. A mineral could define the face, an oil or fat could make a mixture spreadable, wax could help it hold together, and an herb could contribute a therapeutic or sensory role.

The Ebers Papyrus, recorded around 1550 BCE, places this practical activity within a medical framework. Its prescriptions include a beeswax-and-plant-oil preparation for wrinkles, a chemical-peel recipe for blemishes, and preparations intended to protect skin from the arid desert climate. Skin care involved problem-solving across appearance, comfort, and bodily protection. Its identity depended less on a modern label than on its ingredients, method, and intended use.

These records show specific knowledge without standardized production. A preparation's texture, purity, and consistency depended on the materials a maker could obtain and how that maker combined them. That limitation matters because a purposeful recipe could still conceal risks that were difficult to compare, measure, or recognize over time.

The difficulty was not that earlier makers lacked practical intelligence. It was that a visible result could be easier to recognize than a delayed harm. Lead compounds illustrate the imbalance. Galena supplied the powerful black effect of Egyptian kohl, while lead-based Venetian ceruse supplied the white complexion sought in Elizabethan England. In each case, the ingredient's usefulness was apparent in the moment. Its long-term biological cost was not equally visible, and the fact that a preparation worked cosmetically could sustain its desirability.

That distinction changed the nature of the problem. Skin care required not only a substance that could produce an effect, but also a way to control the substance and assess the consequences of using it repeatedly. A safer expectation involved purity, texture, stability, packaging, and repeatability. These were manufacturing questions as much as medical ones. A recipe could be plausible and a result could be visible, yet neither fact guaranteed that the same preparation would behave consistently from one use or maker to the next.

Nineteenth-century petroleum chemistry offered a new answer to this preparation problem. Robert Chesebrough encountered oil-field “rod wax,” a waxy residue associated with the rods and tubing of early oil wells. From that material he extracted a light-colored gel and patented petroleum jelly in 1872. The importance of the development was not simply that petroleum supplied a novel ingredient. It supplied a material base that could be processed into a more uniform topical preparation.

This was a turning point because it joined the older desire for a useful balm to a new demand for industrial control. The topical substance no longer had to remain an irregular residue or a locally mixed compound. Through processing, it could become an object capable of being made repeatedly and distributed beyond the place where its raw materials had first been found. The pursuit of skin care thus moved toward a question that ancient recipes had not institutionalized: could the preparation itself be made predictable?

Vaseline shows how petroleum chemistry changed the physical life of skin care. Robert Chesebrough's 1872 patent followed his extraction of a light-colored gel from oil-field “rod wax,” but extraction alone did not create a mass-market product. The crucial step was refining and purification. His process used distillation to remove lighter oils and filtration to refine the remaining material, producing a balm more uniform than the residue from which it came.

Uniformity freed the topical preparation from a particular maker, batch, or source of ingredients. Refined petroleum jelly could be made repeatedly, placed in a container, transported, identified by a brand, and offered to consumers who had no role in its preparation. The Industrial Revolution helped move cosmetics and skin-care preparations from handcrafted origins toward mass production, making a wider range of products more accessible. Chemistry had reorganized the relationship between maker and user.

Vaseline's uses also show that industrial production did not erase the older overlap between cosmetic and medical purposes. Chesebrough's product was marketed for chapped hands, cuts and bruises, leather, lubrication, and pomade. The same balm could be presented as a skin-care preparation, a treatment, a household aid, or a grooming material. Its standardized base made those uses easier to communicate and repeat.

Packaging extended that reach. Products later appeared in convenient tubes by 1905, making the balm easier to carry and apply. The tube turned a processed material into a consumer object: a user encountered a manageable quantity with a recognizable name rather than an oil-field residue requiring local interpretation.

Standardization, however, did not answer every question. A product could be consistent in texture yet contain an unsafe substance, or be sold for a therapeutic purpose without demonstrating that it worked as claimed. Once topical preparations circulated widely, someone had to judge adulteration, labeling, and therapeutic promises.

Federal regulation changed who could judge a topical product's safety and promises. Before the 1938 United States law, drug manufacturers were not required to submit evidence of safety or efficacy before marketing. That absence became impossible to overlook after the Elixir Sulfanilamide disaster. The product contained diethylene glycol and caused more than 100 deaths across 15 states, exposing the danger of selling a preparation without required premarket evidence of safety.

The Federal Food, Drug, and Cosmetic Act was signed on June 25, 1938. It authorized federal oversight of cosmetics and drugs and targeted adulterated and misbranded products. The law did not make every topical substance a clinically proven treatment. Instead, it created a framework in which the product, its manufacture, and the statements made about it could be examined. Cosmetics entered the federal oversight structure, while the government gained stronger tools, including factory inspections and injunctions. The framework also addressed tolerances for some poisonous substances and prohibited false therapeutic claims for drugs.

The distinction between safety oversight and proof of efficacy matters. A preparation's legal status depended partly on whether it was classified as a cosmetic or a drug, and those categories did not carry identical expectations. Regulation could challenge adulteration and misbranding, and it could address false therapeutic claims for drugs, without making every cosmetic promise equivalent to a demonstrated medical result. The older ambiguity between appearance and treatment remained, but institutions now had to manage it.

For consumers, that changed the meaning of a packaged topical product. Familiarity, visible effectiveness, or local recommendation had once supplied much of a preparation's authority. Industrial balms added uniformity and branding, but not necessarily independent accountability. After 1938, products sold in the United States increasingly entered an institutional arrangement that recognized the dangers of adulteration and misleading claims. Manufacturers faced obligations that did not arise merely from having a workable recipe, and the government possessed authority to inspect and intervene.

Sun care shows how cultural expectations continued to shape that regulated market. Zinc oxide had reportedly been used for centuries as a physical sun block, but the meaning of tanning changed in the 1920s, when a sporting suntan became fashionable and was promoted by Coco Chanel. The popularity of the tanned look helped prompt early commercial sun-care products from Ambre Solaire, Piz Buin, and Coppertone. A protective material entered mass circulation as beauty standards changed, while its public-health significance developed along a different path from fashion.

Skin care became a judged commercial promise when visible results stopped being enough. Egyptian kohl could create a strongly lined eye while carrying protective or medicinal associations; Venetian ceruse could cover smallpox scars and produce a desired pale complexion. Those effects were real as appearances, but neither established safety. The missing pieces were dependable ways to control ingredients, compare preparations, and hold sellers accountable for what they made or claimed.

Petroleum jelly supplied one part of the answer. Robert Chesebrough's extraction, distillation, filtration, and packaging of Vaseline turned an oil-field residue into a standardized, portable balm with uses ranging from chapped hands and cuts to pomade and household lubrication. Federal law supplied another. The 1938 Federal Food, Drug, and Cosmetic Act expanded oversight of cosmetics and drugs and provided tools against adulteration, misbranding, and false therapeutic claims.

Skin care therefore carried its older purposes into a new material and institutional system. Oils, herbs, waxes, and mineral pigments remained part of a desire to alter, protect, or treat the skin, but mass production increasingly shaped how those substances reached consumers. Petroleum chemistry made a balm repeatable and portable; regulation made its condition and representation subjects of public scrutiny. What is in the container, how consistently it is made, what it promises, and who can challenge that promise are now part of what skin care means.